TC
TCG Crossover GP II, LLC cut its GLUE stake below 5%
TCG Crossover GP II, LLC reported owning 4.4% of Monte Rosa Therapeutics, Inc. (GLUE) (3,781,532 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G